Literature DB >> 2879844

Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity.

K E Achyuthan, C S Greenberg.   

Abstract

Guanosine 5'-triphosphate (GTP) was found to inhibit guinea pig liver transglutaminase activity as measured by [3H]putrescine incorporation into casein. GDP and GTP-gamma-S also inhibited enzyme activity (GTP-gamma-S greater than GTP greater than GDP). Kinetic studies showed that GTP acted as a reversible, noncompetitive inhibitor and that CaCl2 partially reversed GTP inhibition. GTP also inhibited rat liver and adult bovine aortic endothelial cell transglutaminase, but did not inhibit Factor XIIIa activity. Guanosine monophosphate (GMP), cyclic GMP, and polyguanylic acid did not inhibit enzyme activity. Guinea pig liver transglutaminase adsorbed well to GTP-agarose affinity columns, but not to CTP-agarose columns, and the binding was inhibited by the presence of calcium ions. Specific binding of GTP to transglutaminase was demonstrated by photoaffinity labeling with 8-azidoguanosine 5'-[gamma-32P] triphosphate, which was inhibited by the presence of GTP or CaCl2. GTP inhibited trypsin proteolysis of guinea pig liver transglutaminase without affecting the trypsin proteolysis of chromogenic substrates. Proteolytic protection was reversed by the addition of calcium. This study demonstrates that GTP binds to transglutaminase and that both GTP and calcium ions function in concert to regulate transglutaminase structure and function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2879844

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling.

Authors:  J Zhang; J Tucholski; M Lesort; R S Jope; G V Johnson
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Inhibition of rat liver transglutaminase by nucleotides.

Authors:  S Kawashima
Journal:  Experientia       Date:  1991-07-15

Review 4.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

5.  The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.

Authors:  Qingmin Ruan; Janusz Tucholski; Soner Gundemir; Gail V W Johnson Voll
Journal:  Int J Clin Exp Med       Date:  2008-06-30

6.  Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.

Authors:  Andrew E L Tee; Glenn M Marshall; Pei Y Liu; Ning Xu; Michelle Haber; Murray D Norris; Siiri E Iismaa; Tao Liu
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

7.  Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.

Authors:  Sunando Datta; Marc A Antonyak; Richard A Cerione
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

8.  A novel function of tissue-type transglutaminase: protein disulphide isomerase.

Authors:  Go Hasegawa; Motoi Suwa; Yasuo Ichikawa; Tetsuro Ohtsuka; Satoru Kumagai; Masashi Kikuchi; Yoshitaka Sato; Yuji Saito
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.

Authors:  Nancy A Muma
Journal:  Med One       Date:  2018-12-05

10.  Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Authors:  Eunsung Junn; Ruben D Ronchetti; Martha M Quezado; Soo-Youl Kim; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.